Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
A record-breaking spin on the coaching carousel is underway across college football. Nine Power Four jobs opened before November, and now eight are availabe after Virginia Tech hired former Penn State ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback